Validation of high performance liquid chromatography coupled to mass spectrometry to determine albendazole sulfoxide in human plasma

• Egile Nagusiak: Jaime Rosales-Rimache (Egilea), Saúl Santiváñez (Egilea), Luis Moreno-Exebio (Egilea), Miguel Grande (Egilea), María Flores-Rodríguez (Egilea), María Eguiluz (Egilea), Hugo García (Egilea)
• Formatua: Liburua
• Argitaratua: GarVal Editorial Ltda., 2022-09-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Context: Albendazole is used in the treatment of cysticercosis and hydatid disease, and its prolonged administration can generate adverse effects attributed to the active metabolite, albendazole sulfoxide (ABZSO), whose measurement requires validated methods that help monitor patients under treatmen...